NCT01460030View on ClinicalTrials.gov

An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

November 30, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

February 28, 2013

Conditions
Parathyroid CarcinomaHypercalcemiaPrimary Hyperparathyroidism
Interventions
DRUG

Cinacalcet HCl

Oral administration

Trial Locations (1)

Unknown

Sendai

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT01460030 - An Intra-individual Titration Study of KRN1493 for the Treatment of Hypercalcemia in Patients With Parathyroid Carcinoma or Intractable Primary Hyperparathyroidism | Biotech Hunter | Biotech Hunter